ArticleACS omega2026
Fluorescent Labeling of Inulin-Based siRNA Delivery Nanocarriers: Implications for Stability and Biological Performance.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluorescently labeled nanoparticles are often implicitly assumed to mimic the behavior of their unlabeled counterparts, despite potential physicochemical perturbations induced by probe conjugation. Herein, we systematically investigated the effect of fluorophore chemistry and labeling density on the colloidal stability and short interfering RNA (siRNA)-binding performance of inulin-based polymeric nanoparticles functionalized with branched polyethylenimine (bPEI) and poly-(D,l-lactic acid) (PLA). Two fluorophores, cyanine 7.5 (Cy7.5) and fluorescein isothiocyanate (FITC), were introduced via distinct conjugation strategies at variable grafting densities. Light scattering analyses revealed probe- and density-dependent modulation of nanoparticle size distribution and surface charge, with high FITC density inducing increased heterogeneity. Polyanion competition and RNase protection assays showed preserved siRNA stability for Cy7.5-labeled nanoparticles, whereas FITC conjugation reduced the level of siRNA retention at high labeling densities. Cellular uptake studies in MC38 cells demonstrated a clear overlap of fluorescent signals from Cy7.5 nanosystems and delivered siRNA under serum-free conditions, while serum proteins promoted partial siRNA displacement. Overall, these results demonstrate that fluorescent labeling is not a neutral modification and must be critically validated to avoid misinterpretation in fluorescence-based nanomedicine studies.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.